[
    [
        {
            "time": "2018-03-01",
            "original_text": "速读社丨新基多发性硬化症药物ozanimod遭FDA拒绝",
            "features": {
                "keywords": [
                    "ozanimod",
                    "FDA",
                    "拒绝",
                    "新基",
                    "多发性硬化症"
                ],
                "sentiment_score": -0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "速读社丨新基多发性硬化症药物ozanimod遭FDA拒绝",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "[增持评级] 医药与健康护理行业月报：重点关注快报、一季报超预期个股",
            "features": {
                "keywords": [
                    "增持",
                    "医药",
                    "健康护理",
                    "一季报",
                    "超预期"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[增持评级] 医药与健康护理行业月报：重点关注快报、一季报超预期个股",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "[买入评级] 乐普医疗(300003)事件点评：完善心血管药品布局 参与竞拍新东港有望增厚业绩",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "心血管",
                    "药品布局",
                    "竞拍",
                    "新东港",
                    "业绩"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[买入评级] 乐普医疗(300003)事件点评：完善心血管药品布局 参与竞拍新东港有望增厚业绩",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "创业板蓝筹股有哪些: 创业板三连阳飙升5.08% 机构调仓换股力荐17",
            "features": {
                "keywords": [
                    "创业板",
                    "蓝筹股",
                    "三连阳",
                    "飙升",
                    "机构推荐"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "创业板蓝筹股有哪些: 创业板三连阳飙升5.08% 机构调仓换股力荐17",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 5,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "[推荐评级] 乐普医疗(300003): 默沙东拟以5.02亿澳元收购乐普参股的溶瘤病毒子公司VIRALYTICS",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "默沙东",
                    "收购",
                    "溶瘤病毒",
                    "VIRALYTICS"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[推荐评级] 乐普医疗(300003): 默沙东拟以5.02亿澳元收购乐普参股的溶瘤病毒子公司VIRALYTICS",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2018-03-01",
            "original_text": "[增持评级] 医药与健康护理行业信息点评：人社部公布按病种付费推荐目录 好国产耗材进口替代",
            "features": {
                "keywords": [
                    "人社部",
                    "按病种付费",
                    "国产耗材",
                    "进口替代"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "[增持评级] 医药与健康护理行业信息点评：人社部公布按病种付费推荐目录 好国产耗材进口替代",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]